514 related articles for article (PubMed ID: 33341879)
1. Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD.
Poletti M; Arnauts K; Ferrante M; Korcsmaros T
J Crohns Colitis; 2021 Jul; 15(7):1222-1235. PubMed ID: 33341879
[TBL] [Abstract][Full Text] [Related]
2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
3. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
4. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Aldars-García L; Marin AC; Chaparro M; Gisbert JP
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
6. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
[TBL] [Abstract][Full Text] [Related]
8. Microbiota and IBD: Current knowledge and future perspectives.
Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A
Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696
[TBL] [Abstract][Full Text] [Related]
9. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
10. Microbiota as Therapeutic Targets.
Xavier RJ
Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
[TBL] [Abstract][Full Text] [Related]
11. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
Fritsch J; Abreu MT
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota and IBD: causation or correlation?
Ni J; Wu GD; Albenberg L; Tomov VT
Nat Rev Gastroenterol Hepatol; 2017 Oct; 14(10):573-584. PubMed ID: 28743984
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases.
Elzayat H; Mesto G; Al-Marzooq F
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571313
[TBL] [Abstract][Full Text] [Related]
14. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
[TBL] [Abstract][Full Text] [Related]
16. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
17. Microbiota, not host origin drives
Arnauts K; Sudhakar P; Verstockt S; Lapierre C; Potche S; Caenepeel C; Verstockt B; Raes J; Vermeire S; Sabino J; Verfaillie C; Ferrante M
Gut Microbes; 2022; 14(1):2089003. PubMed ID: 35758256
[TBL] [Abstract][Full Text] [Related]
18. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
[TBL] [Abstract][Full Text] [Related]
19. Gut mycobiome: The probable determinative role of fungi in IBD patients.
Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
[TBL] [Abstract][Full Text] [Related]
20. Modeling Inflammatory Bowel Disease by Intestinal Organoids.
Di Giorgio C; Roselli R; Biagioli M; Bordoni M; Ricci P; Zampella A; Distrutti E; Donini A; Fiorucci S
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(1):39-53. PubMed ID: 36411558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
